My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 524590 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Hemo Organic Ltd a good quality company?
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Hemo Organic Ltd is a below average quality company.
2. Is Hemo Organic Ltd undervalued or overvalued?
The key valuation ratios of Hemo Organic Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
3. Is Hemo Organic Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemo Organic Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | -10.3% | -6.8% | -7.5% | -38.4% | -19.2% | -39.9% | -43.1% | -11.9% | -44.1% | -89.3% | - | ||
| Value Creation Index ⓘ | -1.7 | -1.5 | -1.5 | -3.7 | -2.4 | -3.9 | -4.1 | -1.9 | -4.2 | -7.4 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0.6 | 0.7 | 0.2 | 0.1 | 0.6 | 0.1 | 0.1 | 0.3 | 0 | 0 | 0 | ||
| YoY Gr. Rt. % | - | 24.6% | -77.5% | -31.3% | 445.5% | -85% | -44.4% | 460% | -96.4% | 0% | - | ||
| Adj EPS ⓘ | -0.7 | -0.4 | -0.3 | -0.9 | -0.2 | -0.4 | -0.4 | -0.1 | -0.1 | -0.2 | -0.2 | ||
| YoY Gr. Rt. % | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - | ||
| BVPS (₹) ⓘ | 4.2 | 4.4 | 3.7 | 1.2 | 1.2 | 0.7 | 0.4 | 0.3 | 0.2 | 0 | 0 | ||
| Adj Net Profit ⓘ | -0.2 | -0.1 | -0.1 | -0.3 | -0.1 | -0.2 | -0.1 | 0 | -0.1 | -0.1 | 0 | ||
| Cash Flow from Ops. ⓘ | -0.4 | 0.1 | 0.1 | -0.8 | -0.2 | -0.1 | 0 | 0 | 0 | 0 | - | ||
| Debt/CF from Ops. ⓘ | -0.7 | 0.7 | 0.7 | 0 | 0 | -0.7 | -2 | 0.3 | -2.6 | -7.9 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | -36.2% | -55.9% | -41.5% | 0% | ||||||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||||||
| BVPS ⓘ | -48.9 | -61.4 | -70.5 | -94.7 | ||||||||
| Share Price | -6.7% | -7.6% | -7.2% | -78.8% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | -13 | -8.4 | -7.8 | -39.5 | -19.2 | -44.9 | -61.4 | -17.5 | -53.4 | -180.2 | -3600 | |
| Op. Profit Mgn % ⓘ | 14.1 | -11 | -38.4 | -50.2 | -13.1 | -170.4 | -219.7 | -6.8 | -591.5 | -909.8 | 0 | |
| Net Profit Mgn % ⓘ | -41.4 | -17.2 | -66.7 | -294.8 | -13.1 | -170.3 | -219.7 | -7.9 | -593.2 | -913.2 | -624.6 | |
| Debt to Equity ⓘ | 0.2 | 0 | 0 | 0 | 0 | 0.3 | 0.6 | 0 | 0.5 | 10.2 | - | |
| Working Cap Days ⓘ | 387 | 169 | 699 | 881 | 368 | 3,622 | 5,397 | 570 | 3,490 | 4,395 | 0 | |
| Cash Conv. Cycle ⓘ | 171 | 118 | 483 | 251 | 61 | 1,002 | 1,569 | -133 | 2,410 | 3,301 | 0 | |
No data to display
Return on Equity is Poor
Sales growth has been subdued in last 3 years -41.52%
Debt to equity has increased versus last 3 years average to 10.21
Sales growth is not so good in last 4 quarters at -25.00%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -0.2 | - |
| TTM Sales (₹ Cr.) | 0 | - |
| BVPS (₹.) ⓘ | 0 | - |
| Reserves (₹ Cr.) ⓘ | -3 | - |
| P/BV ⓘ | 7138.46 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 6.63 / 74.35 |
| All Time Low / High (₹) | 0.50 / 140.40 |
| Market Cap (₹ Cr.) | 3.2 |
| Equity (₹ Cr.) | 3.5 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 36.9 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.
The registered office is located at 8-A, Gulnar Chinar-Gulnar Apartment, V V Nagar Road, Anand, Gujrat - 388001.
The company has posted net profit of Rs 0.04 crore during the quarter ended June 2011 against the break-even during quarter ended June 2010.
Download APP
